Year 2011 / Volume 103 / Number 4
Original
Radio induced cancer risk during ERCP. Is it a real clinical problem?

pp. 191-195

Manuel Luis Rodríguez-Perálvarez, Jose Antonio Miñano-Herrrero, Antonio José Hervás-Molina,José Manuel Benítez-Cantero, Valle García-Sánchez, Antonio Naranjo-Rodríguez, María Pleguezuelo-Navarro, María del Mar Soler-Cantos and Manuel de la Mata-García

Abstract
Background: in recent years many factors have been shown to influence dose received by the patient during ERCP. Therefore it is necessary to update radio induced cancer risk.

Objectives: to calculate lifetime attributable risk of cancer during ERCP. To compare the risk with the most common X-ray examinations.

Design: descriptive study with 393 consecutive ERCP performed at one center. Equipment used was Philips BV pulsera. In each exploration demographic and anthropometric variables of
the patient were collected. Dosimetric quantities were calculated from exposure parameters. Effective dose was estimated using specific conversion factors. Organ doses and radio induced cancer incidence was estimated.

Results: dose area product was 0.82 mGym2 (IQR 0.4-1.5) with an average fluoroscopy time of 2 minutes and 45 seconds.
Entrance surface dose was 30.7 mGy (IQR 15-60.8) and effective dose was 0.44 mSv (IQR 0.2-0.9). Multivariate analysis identified that difficult papillary cannulation (ß0.4; p = 0.009), patient age
(ß-0.01; p = 0.001) and therapeutic applied (ß= 0.89; p < 0.001) influenced dose-area product. The ERCP dose would be equivalent to the radiation received by twenty chest radiographs and
would be about fourteen times smaller than a barium enema or twenty times less than that received during an abdominal CT. Lifetime
attributable risk of cancer incidence was 4.08 and 16.81 per million procedures in diagnostic and therapeutic ERCP respectively.

Conclusions: from the radiological point of view, ERCP is a safe technique that uses low exposure levels compared to other explorations commonly used in medicine. It implies a reasonably
low risk of radio induced cancer.
Share Button
New comment
Comments
No comments for this article
Related articles
Citation tools
Manuel Luis Rodríguez-Perálvarez, Jose Antonio Miñano-Herrrero, Antonio José Hervás-Molina,José Manuel Benítez-Cantero, Valle García-Sánchez, Antonio Naranjo-Rodríguez, María Pleguezuelo-Navarro, María del Mar Soler-Cantos and Manuel de la Mata-García. Radio induced cancer risk during ERCP. Is it a real clinical problem?. 191-195


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 741 visits.
This article has been downloaded 0 times.
Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology